Your browser doesn't support javascript.
loading
A novel somatic mutation achieves partial rescue in a child with Hutchinson-Gilford progeria syndrome.
Bar, Daniel Z; Arlt, Martin F; Brazier, Joan F; Norris, Wendy E; Campbell, Susan E; Chines, Peter; Larrieu, Delphine; Jackson, Stephen P; Collins, Francis S; Glover, Thomas W; Gordon, Leslie B.
Afiliación
  • Bar DZ; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Arlt MF; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.
  • Brazier JF; Center for Gerontology and Health Care Research, Brown University, Providence, Rhode Island, USA.
  • Norris WE; Department of Pediatrics, Hasbro Children's Hospital, Providence, Rhode Island, USA.
  • Campbell SE; Center for Gerontology and Health Care Research, Brown University, Providence, Rhode Island, USA.
  • Chines P; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Larrieu D; Department of Biochemistry, The Gurdon Institute, University of Cambridge, Cambridge, UK.
  • Jackson SP; Department of Biochemistry, The Gurdon Institute, University of Cambridge, Cambridge, UK.
  • Collins FS; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Glover TW; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.
  • Gordon LB; Department of Pediatrics, Hasbro Children's Hospital, Providence, Rhode Island, USA.
J Med Genet ; 54(3): 212-216, 2017 03.
Article en En | MEDLINE | ID: mdl-27920058
BACKGROUND: Hutchinson-Gilford progeria syndrome (HGPS) is a fatal sporadic autosomal dominant premature ageing disease caused by single base mutations that optimise a cryptic splice site within exon 11 of the LMNA gene. The resultant disease-causing protein, progerin, acts as a dominant negative. Disease severity relies partly on progerin levels. METHODS AND RESULTS: We report a novel form of somatic mosaicism, where a child possessed two cell populations with different HGPS disease-producing mutations of the same nucleotide-one producing severe HGPS and one mild HGPS. The proband possessed an intermediate phenotype. The mosaicism was initially discovered when Sanger sequencing showed a c.1968+2T>A mutation in blood DNA and a c.1968+2T>C in DNA from cultured fibroblasts. Deep sequencing of DNA from the proband's blood revealed 4.7% c.1968+2T>C mutation, and 41.3% c.1968+2T>A mutation. CONCLUSIONS: We hypothesise that the germline mutation was c.1968+2T>A, but a rescue event occurred during early development, where the somatic mutation from A to C at 1968+2 provided a selective advantage. This type of mosaicism where a partial phenotypic rescue event results from a second but milder disease-causing mutation in the same nucleotide has not been previously characterised for any disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Progeria / Núcleo Celular / Lamina Tipo A Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Med Genet Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Progeria / Núcleo Celular / Lamina Tipo A Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Med Genet Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos